InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Bridger Gary. Director active across 1 company, notably X4 Pharmaceuticals, Inc. Cumulatively, 4 reports have been logged. Activity tracked since 6 June 2022. The latest transaction was disclosed on 9 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Bridger Gary is a declarant linked to X4 Pharmaceuticals, Inc, where he is listed as Director. The record shows 4 filings, all in the sampled recent filings, with filings published from 2022-06-27 to 2025-06-10, and a transaction nature listed as Attribution.